ImageneBio, Inc. (IMA)
Nasdaq: IMA · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2021
Who owns ImageneBio, Inc.
As filed with the SECHolders of 5% or more
6
Orbimed Advisors LLC holds 13.1% of COMMON STOCK, as its SCHEDULE 13D/A filed Apr 29, 2026 says.
Directors and officers
16
report now, of 30 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
Orbimed Advisors LLC
SCHEDULE 13D/A · filed Apr 29, 2026 · COMMON STOCK · 6.92% in Jul 30, 2025
Bvf Partners L P/il
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.001 par value · 9.9% in May 15, 2026
Trails Edge Capital Partners, LP
SCHEDULE 13G · filed Apr 21, 2026 · Common Stock, $0.001 par value per share
Blue Owl Capital Holdings LP
SCHEDULE 13G/A · filed May 14, 2026 · Common Stock, $0.001 par value · 7.37% in Feb 12, 2026
Omega Fund VI, L.P.
SCHEDULE 13D · filed Apr 21, 2026 · Common Stock, $0.001 par value
Funicular Funds, LP
SCHEDULE 13G · filed Jan 6, 2026 · Common Stock, $0.001 par value
Gilead Sciences, Inc.
SCHEDULE 13G/A · filed Feb 13, 2025 · Common Stock · reported falling below 5%
Atlas Venture Fund X, L.P.
SCHEDULE 13D/A · filed Jul 29, 2025 · Common Stock, $0.001 par value per share · reported falling below 5%
BML Investment Partners, L.P.
SCHEDULE 13D/A · filed Jul 28, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%, from 8.5% in Jun 16, 2025
Deep Track Capital, LP
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, $0.001 par value · reported falling below 5%, from 7.86% in Aug 4, 2025
What IMA reports owning in othersstakes of 5% or more, and other ties
7 subsidiaries in 3 countries, from the list filed with the 10-K filed Mar 10, 2026.
Insider tradesForm 4
2sales
1purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 39 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Slattery Joseph P | director | 0 | $0 | 0 | 1 | $100,000 |
| Lally Robert B | Principal Accounting Officer | 2 | $0 | 0 | 0 | $0 |